The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity
Open accessAbstract
Liver fibrosis, a common scarring response to chronic liver injury, is a precursor to cirrhosis and liver cancer. Here, we identified signal transducer and activator of transcription 1 (STAT1) as an important negative regulator in liver fibrosis. Our findings show that disruption of the STAT1 gene accelerated liver fibrosis and hepatic stellate cell (HSC) proliferation in an in vivo model of carbon tetrachloride (CCl4)-induced liver fibrosis. In vitro treatment with IFN-γ inhibited proliferation and activation of wild-type HSCs, but not STAT1−/− HSCs. Moreover, compared to wild-type cells, cellular proliferation stimulated by serum or platelet-derived growth factor (PDGF) was enhanced and accelerated in STAT1−/− HSCs, which was partially mediated via elevated PDGF receptor β expression on such cells. Polyinosinic-polycytidylic acid (poly I:C) or IFN-γ treatment inhibited liver fibrosis in wild-type mice but not in STAT1−/− mice. Induction of NK cell killing of activated HSCs by poly I:C was attenuated in STAT1−/− mice compared to wild-type mice, which was likely due to reduced NKG2D and TRAIL expression on STAT1−/− NK cells. Finally, activation of TGF-β/Smad3 signaling pathway was accelerated, whereas induction of Smad7 was diminished in the liver of STAT1−/− mice after CCl4 administration compared to wild-type mice. In conclusion , activation of STAT1 attenuates liver fibrosis through inhibition of HSC proliferation, attenuation of TGF-β signaling, and stimulation of NK cell killing of activated HSCs. STAT1 could be a new therapeutic target for treating liver fibrosis. Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,190
Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., Ling, M., & Albrecht, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33023 · Cited by 1,146
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.055 · Cited by 610
Self-citationPinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 478
Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424
Reversal of Hepatic Fibrosis — Fact or Fantasy?
Friedman, S. L., & Bansal, M. B. (2006) · Hepatology · doi:10.1002/hep.20974 · Cited by 379
Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats
Dooley, S., Hamzavi, J., Breitkopf, K., Wiercinska, E., Said, H. M., Lorenzen, J., Ten Dijke, P., & Gressner, A. M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00666-8 · Cited by 369
Tsukada, S., Parsons, C. J., & Rippe, R. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 357
Transforming growth factor β and the liver
Bissell, M. D., Roulot, D., & George, J. (2001) · Hepatology · doi:10.1053/jhep.2001.28457 · Cited by 348
Liver fibrosis: from the bench to clinical targets
Pinzani, M., & Rombouts, K. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.01.003 · Cited by 336
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333
Shi, Z., Wakil, A. E., & Rockey, D. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10663 · Cited by 310
Wong, L., Yamasaki, G., Johnson, R. J., & Friedman, S. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117497 · Cited by 304
Baroni, G. S., D’Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A. M., & Benedetti, A. (1996) · Hepatology · doi:10.1002/hep.510230538 · Cited by 295
Pinzani, M., Milani, S., Herbst, H., DeFranco, R., Grappone, C., Gentilini, A., Caligiuri, A., Pellegrini, G., Ngo, D. V., Romanelli, R. G., et al. (1996) · Europe PMC (PubMed Central) · Cited by 286
Cytokines, STATs and liver disease.
Gao, B. (2005) · PubMed · Cited by 276
Self-citationAnti-Fibrotic Activity of NK Cells in Experimental Liver Injury Through Killing of Activated HSC
Melhem, A., Muhanna, N., Bishara, A., Alvarez, C. E., Ilan, Y., Bishara, T., Horani, A., Nassar, M., Friedman, S. L., & Safadi, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.025 · Cited by 270
Signaling pathways activated by interferons
Platanias, L. C., & Fish, E. N. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00109-5 · Cited by 270
Vignais, M.-L., Sadowski, H. B., Watling, D., Rogers, N. C., & Gilman, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1759 · Cited by 248
PDGF and signal transduction in hepatic stellate cells
Pinzani, M. (2002) · Frontiers in Bioscience · doi:10.2741/a875 · Cited by 239
Taimr, P., Higuchi, H., Kocova, E., Rippe, R. A., Friedman, S., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50002 · Cited by 227
Cammà, C., Di Bona, D., Schepis, F., Heathcote, J. E., Zeuzem, S., Pockros, P. J., Marcellin, P., Balart, L., Alberti, A., & Craxì, A. (2004) · Hepatology · doi:10.1002/hep.20073 · Cited by 227
Ghosh, A. K., Yuan, W., Mori, Y., Chen, S.-J., & Varga, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004709200 · Cited by 225
Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
Duong, F. H. T., Filipowicz, M., Tripodi, M., La Monica, N., & Heim, M. H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.076 · Cited by 222
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
Mallat, A., Preaux, A.-M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., & Mavier, P. (1995) · Hepatology · doi:10.1002/hep.1840210418 · Cited by 180
Inhibition of Rat Hepatic Lipocyte Activation in Culture by Interferon–γ
Rockey, D. C., Maher, J. J., Jarnagin, W. R., Gabbiani, G., & Friedman, S. L. (1992) · Hepatology · doi:10.1002/hep.1840160325 · Cited by 179
TGF-β/Smad Signaling in the Injured Liver
Breitkopf, K., Godoy, P., Ciuclan, L., Singer, M., & Dooley, S. (2006) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-858989 · Cited by 176
Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing
Morishima, C., Paschal, D. M., Wang, C. C., Yoshihara, C. S., Wood, B. L., Yeo, A. E. T., Emerson, S. S., Shuhart, M. C., & Gretch, D. R. (2006) · Hepatology · doi:10.1002/hep.21073 · Cited by 174
Host factors and failure of interferon-α treatment in hepatitis C virus
Gao, B., Hong, F., & Radaeva, S. (2004) · Hepatology · doi:10.1002/hep.20139 · Cited by 159
Self-citationInagaki, Y., Nemoto, T., Kushida, M., Sheng, Y., Higashi, K., Ikeda, K., Kawada, N., Shirasaki, F., Takehara, K., Sugiyama, K., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50408 · Cited by 156
Review: IRF-1 as a Negative Regulator of Cell Proliferation
Romeo, G., Fiorucci, G., Chiantore, M. V., Percario, Z. A., Vannucchi, S., & Affabris, E. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452647 · Cited by 137
Rockey, D. C., & Chung, J. J. (1994) · PubMed · Cited by 135
Expression of platelet-derived growth factor in a model of acute liver injury†
Pinzani, M., Milani, S., Grappone, C., Weber, F. L., Geñtilini, P., & Abboud, H. E. (1994) · Hepatology · doi:10.1002/hep.1840190323 · Cited by 132
Pinzani, M., Gentilini, A., Caligiuri, A., Franco, R. D., Pellegrini, G., Milani, S., Marra, F., & Geñtilini, P. (1995) · Hepatology · doi:10.1002/hep.1840210136 · Cited by 99
Y-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ Effects
Dooley, S., Said, H. M., Gressner, A. M., Floege, J., En‐Nia, A., & Mertens, P. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510215200 · Cited by 95
Delhaye, M., Louis, H., Degraef, C., Moine, O. L., Deviere, J. M. E., Gulbis, B., Jacobovitz, D., Adler, M., & Galand, P. (1996) · Hepatology · doi:10.1002/hep.510230510 · Cited by 91
Weng, H., Wang, B.-E., Jia, J., Wu, W., Xian, J.-Z., Mertens, P. R., Cai, W., & Dooley, S. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00404-0 · Cited by 81
Larrea, E., Aldabe, R., Molano, E., Fernández‐Rodríguez, C., Ametzazurra, A., Civeira, M. P., & Prìeto, J. (2005) · Gut · doi:10.1136/gut.2005.070060 · Cited by 81
Smith, M. W., Walters, K., Korth, M. J., Fitzgibbon, M., Proll, S. C., Thompson, J. C., Yeh, M. M., Shuhart, M. C., Furlong, J. C., Cox, P. P., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.08.015 · Cited by 81
STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice†
Sun, R., Park, O., Horiguchi, N., Kulkarni, S., Jeong, W., Sun, H., Radaeva, S., & Gao, B. (2006) · Hepatology · doi:10.1002/hep.21344 · Cited by 70
Self-citationAntifibrotic Agents for Liver Disease
Albanis, E., & Friedman, S. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01143.x · Cited by 68
Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection
Muir, A. J., Sylvestre, P. B., & Rockey, D. C. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00689.x · Cited by 62
Oben, J. A., Yang, S., Lin, H., Ono, M., & Diehl, A. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02773-0 · Cited by 61
Radaeva, S., Jaruga, B., Kim, W., Heller, T., Liang, T. J., & Gao, B. (2004) · Biochemical Journal · doi:10.1042/bj20031495 · Cited by 31
Self-citationActivation-Induced Cell Death of Hepatic Stellate Cells by the Innate Immune System
Mehal, W. Z. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.048 · Cited by 22
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Self-citationToll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722
Metadata
- Authors
- Jeong, W.-I., Park, O., Radaeva, S., & Gao, B.
- Venue
- Hepatology
- Published
- 2006-12
- Volume
- 44
- Issue
- 6
- Pages
- 1441-1451
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2018346422
- Cited by
- 275
- References
- 49
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.